Azupedia

Vitamin B3/ja: Difference between revisions

Vitamin B3/ja
← Older editNewer edit →
VisualWikitext
Created page with "==食事に関する推奨事項== {{Anchor|Dietary recommendations}}"
Tags: Mobile edit Mobile web edit
Created page with "{| class="wikitable" style="float: right; margin-left: 2em;" |+ 食事に関する推奨事項 | {| class="wikitable mw-collapsible mw-collapsed" style="font-size: 80%; text-align: center; width:406px" |- |+ style="background: blue; color: white; font-size: 110%; text-align: center;" | オーストラリアとニュージーランド |- ! scope="col" style="width:8em" | 年齢層 ! scope="col" style="width:8em" | ナイアシンのRDI (mg NE/day) ! scope="col" style="wid..."
Tags: Mobile edit Mobile web edit
Line 45: Line 45:
{{Anchor|Dietary recommendations}}
{{Anchor|Dietary recommendations}}


<div lang="en" dir="ltr" class="mw-content-ltr">
<div class="mw-translate-fuzzy">
{| class="wikitable" style="float: right; margin-left: 2em;"
{| class="wikitable" style="float: right; margin-left: 2em;"
|+ Dietary recommendations
|+ 食事に関する推奨事項
|
|
{| class="wikitable mw-collapsible mw-collapsed" style="font-size: 80%; text-align: center; width:406px"
{| class="wikitable mw-collapsible mw-collapsed" style="font-size: 80%; text-align: center; width:406px"
|-
|-
|+ style="background: blue; color: white; font-size: 110%; text-align: center;" | Australia and New Zealand
|+ style="background: blue; color: white; font-size: 110%; text-align: center;" | オーストラリアとニュージーランド
|-
|-
! scope="col" style="width:8em" | Age group
! scope="col" style="width:8em" | 年齢層
! scope="col" style="width:8em" | RDI for niacin (mg NE/day)
! scope="col" style="width:8em" | ナイアシンのRDI (mg NE/day)
! scope="col" style="width:8em" | Upper level of intake
! scope="col" style="width:8em" | 摂取量の上限レベル
|-
|-
| Infants 0–6 months || 2&nbsp;mg/d preformed niacin* || rowspan="2"| ND
| 幼児 0–6ヶ月 || 2&nbsp;mg/d プリフォームド・ナイアシン* || rowspan="2"| ND
|-
|-
| Infants 7–12 months || 4&nbsp;mg/d NE*
| 幼児 7–12ヶ月 || 4&nbsp;mg/d NE*
|-
|-
| 1–3 || 6 || 10
| 1–3 || 6 || 10
Line 71: Line 71:
| 19+ || – || 35
| 19+ || – || 35
|-
|-
| Females 14+ || 14 || rowspan=2 | –
| 女性 14+ || 14 || rowspan=2 | –
|-
|-
| Males 14+ || 16
| 男性 14+ || 16
|-
|-
| Pregnant females 14–50 || 18 || –
| 妊娠中の女性 14–50 || 18 || –
|-
|-
| Pregnant females 14–18 || – || 30
| 妊娠中の女性 14–18 || – || 30
|-
|-
| Pregnant females 19–50 || – || 35
| 妊娠中の女性 19–50 || – || 35
|-
|-
| Lactating females 14–50 || 17 || –
| 授乳中の女性 14–50 || 17 || –
|-
|-
| Lactating females 14–18 || – || 30
| 授乳中の女性 14–18 || – || 30
|-
|-
| Lactating females 19–50 || – || 35
| 授乳中の女性 19–50 || – || 35
|-
|-
| colspan="3" style="text-align: center;" | * Adequate Intake for infants
| colspan="3" style="text-align: center;" | * 乳児の適切な摂取量
|-
|-
|}
|}
{| class="wikitable mw-collapsible mw-collapsed" style="font-size: 80%; text-align: center; width:406px"
{| class="wikitable mw-collapsible mw-collapsed" style="font-size: 80%; text-align: center; width:406px"
|-
|-
|+ style="background: blue; color: white; font-size: 110%; text-align: center;" | Canada
|+ style="background: blue; color: white; font-size: 110%; text-align: center;" | カナダ
|-
|-
! scope="col" style="width:8em" | Age group (years)
! scope="col" style="width:8em" | 年齢層 (歳)
! scope="col" style="width:8em" | RDA of niacin (mg NE/d)
! scope="col" style="width:8em" | ナイアシンのRDA (mg NE/d)
! scope="col" style="width:8em" | Tolerable upper intake level
! scope="col" style="width:8em" | 許容上限摂取量
|-
|-
| 0–6 months || 2&nbsp;mg/d preformed niacin* || rowspan=2| ND
| 0–6 months || 2&nbsp;mg/d プリフォームド・ナイアシン* || rowspan=2| ND
|-
|-
| 7–12 months || 4&nbsp;mg/d NE*
| 7–12ヶ月 || 4&nbsp;mg/d NE*
|-
|-
| 1–3 || 6 || 10
| 1–3 || 6 || 10
Line 108: Line 108:
| 9–13 || 12 || 20
| 9–13 || 12 || 20
|-
|-
| Females 14–18 || 14 || rowspan=2| 30
| 女性 14–18 || 14 || rowspan=2| 30
|-
|-
| Males 14–18 || 16
| 男性 14–18 || 16
|-
|-
| Females 19+ || 14 || rowspan=2| 35
| 女性 19+ || 14 || rowspan=2| 35
|-
|-
| Males 19+ || 16
| 男性 19+ || 16
|-
|-
| Pregnant females <18 || 18 || 30
| 妊娠中の女性 <18 || 18 || 30
|-
|-
| Pregnant females 18–50 || 18 || 35
| 妊娠中の女性 18–50 || 18 || 35
|-
|-
| Lactating females <18 || 17 || 30
| 授乳中の女性 <18 || 17 || 30
|-
|-
| Lactating females 18–50 || 17 || 35
| 授乳中の女性 18–50 || 17 || 35
|-
|-
|}
|}
{| class="wikitable mw-collapsible mw-collapsed" style="font-size: 80%; text-align: center; width:406px"
{| class="wikitable mw-collapsible mw-collapsed" style="font-size: 80%; text-align: center; width:406px"
|-
|-
|+ style="background: blue; color: white; font-size: 110%; text-align: center;" | European Food Safety Authority
|+ style="background: blue; color: white; font-size: 110%; text-align: center;" | 欧州食品安全機関
|-
|-
! scope="col" width=8em | Gender
! scope="col" width=8em | 性別
! colspan=2 width=16em | Adequate Intake (mg NE/MJ)
! colspan=2 width=16em | 十分な摂取量 (mg NE/MJ)
|-
|-
| Females || colspan=2 width="8em"| 1.3
| 女性 || colspan=2 width="8em"| 1.3
|-
|-
| Males || colspan=2 width="8em"| 1.6
| 男性 || colspan=2 width="8em"| 1.6
|-
|-
! scope="col" style="width:8em" | Age (years)
! scope="col" style="width:8em" | 年齢 (歳)
! scope="col" style="width:8em" | Tolerable upper limit of Nicotinic acid (mg/day)
! scope="col" style="width:8em" | ニコチン酸の許容上限値 (mg/day)
! scope="col" style="width:8em" | Tolerable upper limit of Nicotinamide (mg/day)
! scope="col" style="width:8em" | ニコチンアミドの耐容上限量 (mg/day)
|-
|-
| 1–3 || 2 || 150
| 1–3 || 2 || 150
Line 153: Line 153:
{| class="wikitable mw-collapsible mw-collapsed" style="font-size: 80%; text-align: center; width:406px"
{| class="wikitable mw-collapsible mw-collapsed" style="font-size: 80%; text-align: center; width:406px"
|-
|-
|+ style="background: blue; color: white; font-size: 110%; text-align: center;" | United States
|+ style="background: blue; color: white; font-size: 110%; text-align: center;" | 米国
|-
|-
! scope="col" style="width:8em" | Age group
! scope="col" style="width:8em" | 年齢層
! scope="col" style="width:8em" | RDA for niacin (mg NE/day)
! scope="col" style="width:8em" | ナイアシンのRDA (mg NE/day)
! scope="col" style="width:8em" | Tolerable upper intake level
! scope="col" style="width:8em" | 許容上限摂取量
|-
|-
| Infants 0–6 months || 2* || rowspan="2"| ND**
| 幼児 0–6ヶ月 || 2* || rowspan="2"| ND**
|-
|-
| Infants 6–12 months || 4*
| 幼児 6–12ヶ月 || 4*
|-
|-
| 1–3 || 6 || 10
| 1–3 || 6 || 10
Line 169: Line 169:
| 9–13 || 12 || 20
| 9–13 || 12 || 20
|-
|-
| Females 14–18 || 14 || 30
| 女性 14–18 || 14 || 30
|-
|-
| Males 14–18 || 16 || 30
| 男性 14–18 || 16 || 30
|-
|-
| Females 19+ || 14 || 35
| 女性 19+ || 14 || 35
|-
|-
| Males 19+ || 16 || 35
| 男性 19+ || 16 || 35
|-
|-
| Pregnant females 14–18 || 18 || 30
| 妊娠中の女性 14–18 || 18 || 30
|-
|-
| Pregnant females 19–50 || 18 || 35
| 妊娠中の女性 19–50 || 18 || 35
|-
|-
| Lactating females 14–18 || 17 || 30
| 授乳中の女性 14–18 || 17 || 30
|-
|-
| Lactating females 19–50 || 17 || 35
| 授乳中の女性 19–50 || 17 || 35
|-
|-
| colspan="3" style="text-align: center;" | * Adequate intake for infants, as an RDA has yet to be established<br />** Not possible to establish; source of intake should be formula and food only
| colspan="3" style="text-align: center;" | * RDA はまだ確立されていないため、乳児の十分な摂取量<br />** 確立は不可能である；
摂取源は粉ミルクと食事のみとする。
|-
|-
|}
|}
|}
|}
The U.S. Institute of Medicine (renamed [[National Academy of Medicine]] in 2015) updated Estimated Average Requirements (EARs) and Recommended Dietary Allowances (RDAs) for niacin in 1998, as well as [[Tolerable upper intake levels]] (ULs). In lieu of an RDA, Adequate Intakes (AIs) are identified for populations for which there is not enough evidence to identify a dietary intake level that is sufficient to meet the nutrient requirements of most people. (see table).
米国医学研究所（2015年に[[:en:National Academy of Medicine|米国医学アカデミー]]に改称）は、1998年にナイアシンの推定平均必要量（EAR）と推奨食事許容量（RDA）、および[[耐容上限摂取量レベル]]（UL）を更新した。RDAの代わりに、ほとんどの人々の栄養所要量を満たすのに十分な食事摂取レベルを特定するのに十分な証拠がない集団については、十分摂取量（AAI）が特定される。(表参照）。
</div>
</div>


Retrieved from "https://wiki.tiffa.net/wiki/Vitamin_B3/ja"